Skip to main content
Premium Trial:

Request an Annual Quote

Genzyme Molecular Oncology Will Access Dana-Farber Technology


FRAMINGHAM, Mass.--Genzyme Molecular Oncology announced that it has entered into an agreement with the Dana-Farber Cancer Institute that will give the company an option to exclusively license novel fusion cell technology developed by researchers at Dana-Farber. Genzyme Molecular also said it has initiated funding at the institute.

Genzyme Molecular plans to combine fusion cell technology--the subject of a study published last month in the Proceedings of the National Academy of Sciences--with proprietary technologies such as Serial Analysis of Gene Expres sion, and Solid Phase Epitope Recovery, in an integrated antigen discovery program. Genzyme Molecular develops gene-based approaches to cancer therapy and diagnosis and employs an integrated approach to translate information gained through its genomics capabilities into gene therapy, small molecule therapeutics, and genetic diagnostics. Genzyme Molecular Oncology is a division of biotechnology company Genzyme and has its own common stock, not yet publicly traded.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.